Oliver Hartley , Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting Hartley will also present new data on Orion’s CCR2 antagonist, OB-004, demonstrating the ability of this

Oliver Hartley. Below is your Classified GPCR News at a glance for March 20th to 26th, 2023.

Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr. Ben Myers and Dr.

Oliver Smithies at UNC-CH, where she was the first to discover the essential role of adrenomedullin peptide

Monserrat Avila Zozaya & Yamina Berchiche About Inês Pinheiro PharmD by training and Ph.D. candidate in Hartley's

Inês Pinheiro PharmD by training and Ph.D. candidate in Hartley's lab at the University of Geneva.